- Home
- /
- Treatment
- /
- Page 59
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Omeprazole-lansoprazoe with buffer | Esophageal ulcers | Effexus Pharmaceuticals, LLC;10901 Granada Lane, Suite 101;Leawood, KS, 66211 | February 10, 2015 | |
Recombinant monoclonal antibody to human serum amyloid P component | AL amyloidosis | Glaxo Group Limited, England d/b/a GlaxoSmithKline;980 Great West Road, Middlesex, TW8, 9GS; | February 10, 2015 | |
Bivalent anti-human myostatin adnectin-IgG1 | Duchenne muscular dystrophy | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | February 10, 2015 | |
Copanlisib | Follicular lymphoma | Bayer US LLC;100 Bayer Boulevard, P. O. Box 915;Hanover, New Jersey, 07981 | February 5, 2015 | |
Antinuclear antibody conjugated liposomal doxorubicin | Ewing's sarcoma | NanoSmart Pharmaceuticals, Inc.;27071 Cabot Road, Suite 104;Laguna Hills, California, 92653 | February 3, 2015 | |
Bortezomib | Acute lymphoblastic leukemia | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 | February 3, 2015 | |
N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide | Non-small cell lung cancer | Ignyta, Inc.;4545 Towne Centre Court;San Diego, California, 92121 | February 3, 2015 | |
N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide | TrkA-positive, TrkB-positive, TrkC-positive ROS1-positive and ALK-positive non-small cell lung cancer | Ignyta, Inc.;11095 Flintkote Avenue, Suite D;San Diego, CA, 92121 | February 3, 2015 | |
Alectinib | Non-small cell lung cancer | Hoffmann-La Roche, Inc. (c/o Genentech, Inc.);1 DNA Way, MS #355E;South San Francisco, California, 94080 | January 27, 2015 | |
Filgrastim | Amyotrophic lateral sclerosis | Neurovision Pharma GmbH;Emil-Geis Str. 4;Grunwald | January 27, 2015 | |
18Fluorine-N-3-Fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) Nortropane | Multiple system atrophy | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 | January 26, 2015 | |
Theranost 68Ga RGD | Diagnostic for the clinical management of patients with tuberculosis | Advanced Imaging Projects, LLC;FL ATlantic University Research Park, 3651 FAU Blvd;Boca Raton, Florida, 33431 | January 26, 2015 | |
(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile | Pemphigus vulgaris | Almirall S.A.;Ronda General Mitre, 151;Barcelona | January 26, 2015 | |
Double stranded RNA which targets the mutated KRAS oncogene | Pancreatic Cancer | Silenseed Ltd;Goldyne Savad Institute of Gene Therapy, Jerusalem, 9112001; | January 26, 2015 | |
2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate | Pancreatic Cancer | Incyte Corporation;1801 Augustine Cut-Off;Wilmington, Delaware, 19803 | January 26, 2015 | |
8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one | Glioblastoma | Diffusion Pharmaceuticals, Inc.;2020 Avon Court, Suite 4;Charlottesville, Virginia, 22902 | January 21, 2015 | |
Antroquinonol | Pancreatic Cancer | Golden Biotechnology Corp.;10F., No. 9, Ln 3, Tamsui Dist., New Taipei City 251; | January 21, 2015 | |
5-(4-Cyclopropyl-1H-imidazol-l-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide | Pulmonary Arterial Hypertension | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | January 15, 2015 | |
2,5-dimethyl-3-[2-methyl-4-(methyloxy)phenyl]-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5- | Congenital adrenal hyperplasia | Neurocrine Biosciences, Inc.;12780 El Camino Real;San Diego, California, 92130 | January 15, 2015 | |
Autologous CD34+ bone marrow derived stem cells transduced with a self-inactivating gammaretroviral vector encoding the human IL2RG (yc) | Severe combined immune deficiency-X1 | Boston Children's Hospital;Div. of Hematology/Oncology, Karp 08215;Boston, Massachusetts, 02115 | January 15, 2015 | |
Arimoclomol citrate | Neimann-Pick disease, type C | Orphazyme ApS;Ole Maaloes Vej 3, 2200 Copenhagen; | January 13, 2015 | |
Deutetrabenazine | Tourette syndrome | TEVA Pharmaceuticals;3366 North Torrey Pines Court, Suite 225;LaJolla, California, 92037 | January 13, 2015 | |
Anti-Beta 1 integrin monoclonal antibody | Ovarian cancer | OncoSynergy, Inc.;409 Illinois Street, Room 3044;San Francisco, CA, 94158-2509 | January 13, 2015 | |
N-[2,6-bis(1-methylethyl)phenyl]-N’-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt | Cushing’s syndrome | Millendo Therapeutics, Inc.;301 North Main St., Suite 100;Ann Arbor,, Michigan, 48104 | January 7, 2015 | |
Pentosan polysulfate sodium | Mucopolysaccharidosis type VI | Plexcera Therapeutics, LLC;4445 North Highway A1A, Suite 241;Vero Beach, Florida, 32963 | January 5, 2015 |